| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| LGALS3 |
1-[(2R,3R,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methylsulfanyloxan-4-yl]-N-(2-morpholin-4-ylethyl)triazole-4-carboxamide |
NA |
NA |
520000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-4-[4-(2-fluorophenyl)triazol-1-yl]-2-(hydroxymethyl)-6-methylsulfanyloxane-3,5-diol |
NA |
NA |
200000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
Methyl-3-(4-butylaminocarbonyl-1H-[1,2,3]-triazol-1-yl)-3-deoxy-1-thio-beta-D-galactopyranoside |
NA |
NA |
150000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-4-[4-(1-hydroxycyclohexyl)triazol-1-yl]-2-(hydroxymethyl)-6-methylsulfanyloxane-3,5-diol |
NA |
NA |
1600000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
1-[(2R,3R,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methylsulfanyloxan-4-yl]-N-(3-hydroxypropyl)triazole-4-carboxamide |
NA |
NA |
360000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methylsulfanyl-4-(4-naphthalen-1-yltriazol-1-yl)oxane-3,5-diol |
NA |
NA |
120000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methylsulfanyl-4-(4-pyridin-3-yltriazol-1-yl)oxane-3,5-diol |
NA |
NA |
1900000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
Methyl 3-(4-methoxycarbonyl-1h-[1,2,3]-triazol-1-yl)-3-deoxy-1-thio-beta-d-galactopyranoside |
NA |
NA |
1300000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-4-[4-(4-methoxyphenyl)triazol-1-yl]-6-methylsulfanyloxane-3,5-diol |
NA |
NA |
260000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
N-benzyl-1-((2R,3R,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-(methylthio)-tetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazole-4-carboxamide |
NA |
NA |
110000|150000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-4-[4-(3-methoxyphenyl)triazol-1-yl]-6-methylsulfanyloxane-3,5-diol |
NA |
NA |
130000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
Methyl-3-(4-methylaminocarbonyl-1H-[1,2,3]-triazol-1-yl)-3-deoxy-1-thio-beta-D-galactopyranoside |
NA |
NA |
230000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(NZ)-4-methyl-N-[3-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]chromen-2-ylidene]benzenesulfonamide |
NA |
NA |
10000000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(NZ)-N-[3-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]chromen-2-ylidene]-4-methylbenzenesulfonamide |
NA |
NA |
130000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
(NZ)-N-[3-[[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxymethyl]chromen-2-ylidene]-4-methylbenzenesulfonamide |
NA |
NA |
120000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
[(2S,3R,4S,5S,6R)-4-[[(2Z)-2-(benzenesulfonylimino)chromen-3-yl]methoxy]-5-hydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl] acetate |
NA |
NA |
130000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
Beta-methyllactoside |
NA |
NA |
220000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
N-(2,4-dichlorophenyl)sulfonyl-6-(4-propan-2-ylphenoxy)-1H-indole-2-carboxamide |
NA |
NA |
783700 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
N-[4-[4-[[(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxymethyl]triazol-1-yl]phenyl]sulfonylacetamide |
NA |
NA |
NA |
205000 |
NA |
NA |
BindingDB|TTD |
| LGALS3 |
(2R,3R,4S,5R,6R)-2-(3,4-dichlorophenyl)sulfanyl-4-(3,4-dimethylanilino)-6-(hydroxymethyl)oxane-3,5-diol |
NA |
NA |
170000 |
NA |
NA |
NA |
BindingDB |